BRISBANE, Calif., May 7, 2015 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial results for the first quarter ended March 31, 2015.
Key financial highlights for the first quarter of 2015 were as follows:
- Revenue increased 18% to $19.1 million, compared to the same period last year, resulting primarily from recently launched new products, enlightenTM and excel HRTM.
- Product revenue grew 48% in North America and 34% from Rest of the World ("ROW").
- Gross margin was 53% reflecting a higher level of distributor volume, the unfavorable impact of devalued foreign currencies versus the US dollar, and higher initial manufacturing costs associated with recently launched products.
- Net loss was $3.6 million, or $0.25 per diluted share. This includes approximately $0.5 million of non-recurring sales expenses related to the restructuring of the North American sales team, and $1.3 million of non-cash expenses related to stock-based compensation, depreciation and intangible amortization.
- Stock repurchased during the quarter was 386,155 shares for $5.2 million.
- Cash and investments balance as of March 31, 2015 was $76.1 million.
Kevin Connors, President and Chief Executive Officer of Cutera, stated, "I am pleased with our first quarter 2015 revenue of $19.1 million, which represents the highest first quarter revenue since 2008. Revenue from products grew year-over-year by 48% in North America and 34% in ROW, which demonstrates that our commercial investments and new product launches are yielding solid revenue growth momentum. ROW growth was particularly impressive given the significant decline of the Japanese Yen, Euro and Australian dollar when compared to the same period in 2014. Our international revenue growth was fueled primarily in Europe, and secondarily through existing and new distributors in other regions.
"Revenue from enlighten, our picosecond and nanosecond tattoo removal and benign pigmented lesion treatment laser, has been steadily increasing on a sequential basis and is continuing to gain momentum as we obtain international regulatory clearances, increase the customer reference base, and build the necessary support structure for this product. enlighten is cleared for sale in several countriessuch as South Korea, Australia, and the European Union and we are actively pursuing approvals in additional countries.
"Our first quarter gross margin of 53% was lower than we had previously expected. This was driven by a combination of higher than usual percentage of distributor business, unfavorable foreign currency headwinds, and higher initial manufacturing costs for our new products. We anticipate that cost reductions and manufacturing efficiencies will materially improve gross margin for recently launched products, resulting in steadily improving gross margin for the remainder of 2015.
"While there are unpredictable factors, including unfavorable currency movements, that may impact our global business, we believe the market for aesthetic light-and-energy-based-systems is healthy and expanding," concluded Kevin Connors.
The conference call to discuss these results is scheduled to begin at 2:00 p.m. PST (5:00 p.m. EST) on May 7, 2015. Participating in the call will be Kevin Connors, President and Chief Executive Officer, and Ron Santilli, Executive Vice President and Chief Financial Officer. The call will be broadcast live over the Internet hosted at the Investor Relations section of Cutera's website, and will be archived online within one hour of its completion through 8:59 p.m. PST (11:59 p.m. EST) on May 21, 2015. In addition, you may call 1-877-705-6003 to listen to the live broadcast.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Specifically, statements concerning Cutera's ability to increase revenue, reduce expenses, make productivity improvements, develop and commercialize existing and new products and applications, grow the Company's market share, and realize benefits from additional investment and statements regarding long-term prospects and opportunities in the laser and other energy-based equipment aesthetic market are forward-looking statements within the meaning of the Safe Harbor. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. Potential risks and uncertainties that could affect Cutera's business and cause its financial results to differ materially from those contained in the forward-looking statements include those related to the Company's efforts to improve sales productivity, hire and retain qualified sales representatives, improve revenue growth, gross margins and profitability through leveraging operating expenses; the Company's ability to successfully develop and launch new products and applications and market them to both its installed base and new customers; unforeseen events and circumstances relating to the Company's operations; government regulatory actions; the timing and success in obtain regulatory approvals for selling and marketing the Company's products; and those other factors described in the section entitled, "Risk Factors" in its most recent Form 10-Q as filed with the Securities and Exchange Commission on May 7th, 2015. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. Cutera's financial performance for the first quarter ended March 31, 2015, as discussed in this release, is preliminary and unaudited, and subject to adjustment.
|CONDENSED CONSOLIDATED BALANCE SHEETS|
|March 31,||December 31,||March 31,|
|Cash and cash equivalents||$ 13,462||$ 9,803||$ 10,743|
|Cash, cash equivalents and marketable investments||76,057||81,146||83,822|
|Accounts receivable, net||10,400||11,137||6,588|
|Deferred tax asset||26||26||31|
|Other current assets and prepaid expenses||1,699||1,591||2,404|
|Total current assets||100,037||104,888||102,485|
|Property and equipment, net||1,545||1,461||1,358|
|Deferred tax asset, net of current portion||291||269||337|
|Other long-term assets||362||361||21|
|Total assets||$ 104,024||$ 108,913||$ 107,365|
|Liabilities and Stockholders' Equity|
|Accounts payable||$ 2,855||$ 3,083||$ 2,483|
|Total current liabilities||20,772||22,988||18,346|
|Deferred revenue, net of current portion||3,714||4,346||4,324|
|Income tax liability||167||145||118|
|Other long-term liabilities||798||926||1,200|
|Total liabilities and stockholders' equity||$ 104,024||$ 108,913||$ 107,365|
|CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS|
|(in thousands, except per share data)|
|Three Months Ended|
|March 31,||March 31,|
|Net revenue||$ 19,071||$ 16,189|
|Cost of revenue||9,052||7,303|
|Gross margin %||53%||55%|
|Sales and marketing||8,187||7,331|
|Research and development||2,445||2,644|
|General and administrative||2,989||2,564|
|Total operating expenses||13,621||12,539|
|Loss from operations||(3,602)||(3,653)|
|Interest and other income, net||8||80|
|Loss before income taxes||(3,594)||(3,573)|
|Provision for income taxes||50||37|
|Net loss||$ (3,644)||$ (3,610)|
|Net loss per share:|
|Basic and diluted||$ (0.25)||$ (0.26)|
|Weighted-average number of shares used in per share calculations:|
|Basic and diluted||14,611||14,021|
|CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS|
|Three Months Ended|
|March 31,||March 31,|
|Cash flows from operating activities:|
|Net loss||$ (3,644)||$ (3,610)|
|Adjustments to reconcile net loss to net cash used in operating activities:|
|Depreciation and amortization||327||331|
|Changes in assets and liabilities:|
|Net cash provided by (used in) operating activities||(6,014)||(972)|
|Cash flows from investing activities:|
|Acquisition of property, equipment and software||(407)||(239)|
|Net change in marketable investments||8,689||(6,351)|
|Net cash provided by (used in) investing activities||8,282||(6,590)|
|Cash flows from financing activities:|
|Repurchases of common stock||(4,550)||—|
|Proceeds from exercise of stock options and employee stock purchase plan||6,002||2,096|
|Payments on capital lease obligations||(61)||(33)|
|Net cash provided by (used in) financing activities||1,391||2,063|
|Net increase (decrease) in cash and cash equivalents||3,659||(5,499)|
|Cash and cash equivalents at beginning of period||9,803||16,242|
|Cash and cash equivalents at end of period||$ 13,462||$ 10,743|
|Supplemental disclosure of non-cash items:|
|Repurchase of common stock acquired but not settled||$ 656||$ --|
|CONSOLIDATED FINANCIAL HIGHLIGHTS|
|(in thousands, except percentage data)|
|Three Months Ended||% Change|
|Q1||Q1||Q1 '15 Vs|
|Revenue By Geography:|
|United States||$ 7,792||6,017||+29%|
|International as a percentage of total revenue||59%||63%|
|Revenue By Product Category:|
|-North America||$ 5,677||$ 3,832||+48%|
|-Rest of the World||7,561||5,652||+34%|
|Hand Piece Refills||764||1,041||-27%|
|$ 19,071||$ 16,189||+18%|
|Three Months Ended|
|Pre-tax Stock-Based Compensation Expense:|
|Cost of revenue||$ 103||$ 132|
|Sales and marketing||185||71|
|Research and development||182||124|
|General and administrative||491||298|
|$ 961||$ 625|
CONTACT: Ron Santilli Chief Financial Officer 415-657-5500 Investor Relations John Mills Integrated Corporate Relations, Inc. 646-277-1254 email@example.com